Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rihab Nasr

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Viruses|October 14, 2011
Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?Rihab Nasr, Hiba El Hajj, Youmna Kfoury, et al.
Frontiers in Microbiology|July 9, 2020
Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia LymphomaKunihiro Tsukasaki, Ambroise Marçais, Rihab Nasr, et al.
Molecular Oncology|March 5, 2013
How animal models of leukaemias have already benefited patientsJulien Ablain, Rihab Nasr, Jun Zhu, et al.
The Lancet. Oncology|November 4, 2021
National cancer control plans across the Eastern Mediterranean region: challenges and opportunities to scale-upIbtihal Fadhil, Eman Alkhalawi, Rihab Nasr, et al.
Haematologica|May 19, 2019
Validation of a <i>Drosophila</i> model of wild-type and T315I mutated BCR-ABL1 in chronic myeloid leukemia: an effective platform for treatment screeningAmani Al Outa, Dana Abubaker, Ali Bazarbachi, et al.
Nutrition and Cancer|September 25, 2020
Nutrition and Breast Cancer Research in Arab Countries: Gaps, Opportunities, and RecommendationsHibeh Shatila, Zaynab Fatfat, Rabih Talhouk, et al.
Biomedicines|August 26, 2023
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!Ghada Chamandi, Layal El-Hajjar, Abdallah El Kurdi, et al.
Diseases (Basel, Switzerland)|May 26, 2026
Cancer Patterns and Barriers to Care Among Socioeconomically Vulnerable Populations in Tripoli: A Descriptive Study from a Local NGOMouhamad J Darwich, Dalal Ksair, Zein Adra, et al.
The Lancet. Oncology|November 4, 2004
New therapeutic approaches for adult T-cell leukaemiaAli Bazarbachi, David Ghez, Yves Lepelletier, et al.
Scientific Reports|December 20, 2022
Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epitheliumNataly Naser Al Deen, Nadia Atallah Lanman, Shirisha Chittiboyina, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Viruses|October 14, 2011
Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?Rihab Nasr, Hiba El Hajj, Youmna Kfoury, et al.
Frontiers in Microbiology|July 9, 2020
Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia LymphomaKunihiro Tsukasaki, Ambroise Marçais, Rihab Nasr, et al.
Molecular Oncology|March 5, 2013
How animal models of leukaemias have already benefited patientsJulien Ablain, Rihab Nasr, Jun Zhu, et al.
The Lancet. Oncology|November 4, 2021
National cancer control plans across the Eastern Mediterranean region: challenges and opportunities to scale-upIbtihal Fadhil, Eman Alkhalawi, Rihab Nasr, et al.
Haematologica|May 19, 2019
Validation of a <i>Drosophila</i> model of wild-type and T315I mutated BCR-ABL1 in chronic myeloid leukemia: an effective platform for treatment screeningAmani Al Outa, Dana Abubaker, Ali Bazarbachi, et al.
Nutrition and Cancer|September 25, 2020
Nutrition and Breast Cancer Research in Arab Countries: Gaps, Opportunities, and RecommendationsHibeh Shatila, Zaynab Fatfat, Rabih Talhouk, et al.
Biomedicines|August 26, 2023
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!Ghada Chamandi, Layal El-Hajjar, Abdallah El Kurdi, et al.
Diseases (Basel, Switzerland)|May 26, 2026
Cancer Patterns and Barriers to Care Among Socioeconomically Vulnerable Populations in Tripoli: A Descriptive Study from a Local NGOMouhamad J Darwich, Dalal Ksair, Zein Adra, et al.
The Lancet. Oncology|November 4, 2004
New therapeutic approaches for adult T-cell leukaemiaAli Bazarbachi, David Ghez, Yves Lepelletier, et al.
Scientific Reports|December 20, 2022
Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epitheliumNataly Naser Al Deen, Nadia Atallah Lanman, Shirisha Chittiboyina, et al.
Pageof 8